Inför Q2-rapporten räknar Analysguiden med en liknade utvecklingen som i det första kvartalet, med a...
Redeye maintains a positive outlook on Nanologica following its Q2 report.
Redeye comments on Fantasma Games ahead of its Q2 results, due on 7 August.
Redeye comments on Freemelt ahead of its Q2 results, due on 6 August.
Redeye comments on Raketech’s divestment of its US high-touch tipster advisory business as it increa...
- Q2 due Thursday, 18 July, 08:30 CET - We expect lukewarm orders, but a continued high gross margin...
On July 4, after trading closed on Oslo Børs, EG informed Carasent it will not proceed with an offer...
Ahead of Svedbergs Group's Q2 report on 18 July, we expect a decent quarter, with a 1% organic sales...
Q2e: return to growth as comps ease For Q2, we expect sales of SEK 45m, up 10% y-o-y, marking a retu...
Q2e: limited developments In Q2, we expect SEK 279m in order intake, down 2% y-o-y, and sales of SEK...
Q2e: in line with Q1, easy y-o-y comps We expect Q2 sales of SEK 52m, up 26% y-o-y vs.
Cultural and customer similarities bode well Prevas has received regulatory clearance for its acquis...
Redeye comments on Genovis following the announcement of a strategic investment in SEQURNA, a develo...
Solwers’ subsidiary Davidsson Tarkela Architects Oy has today signed an agreement to acquire 100% of...
Earnings capacity IFPM +3.5% vs ABGSCe Eastnine delivered a Q2 report with rental income of EUR 9.
AAC Clyde Space has announced the acquisition of Spacemetric for a total consideration of SEK25m (in...
Förvaltningsresultat ökade med 26% på årsbasis drivet av främst ränteintäkter.
Redeye comments on the directed share issue, new cooperation with Presto, and the subsequent initial...
Q2'24e expectations We forecast flat (0%) organic growth rate for Vitrolife and a marginally higher ...
Redeye comments on the Paxman contract with the US Veterans Association as a sole contractor with th...
